Pharmaceutical Technology
SEPTEMBER 8, 2022
Pharmaceutical solid dose manufacturing companies in contract marketing segment have gained a vital position in pharmaceutical formulations. Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drug delivery methods across patient groups.
Pharmaceutical Technology
NOVEMBER 15, 2022
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. Cost is an important final factor, especially for small and mid-sized pharma companies. Prefilled syringes offer a number of advantages over the more traditional glass vial.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 1, 2021
” The tie-up with neuroloop and B Braun will bring together their expertise in this area with Merck’s knowhow in “electronics, medicines and drug delivery,” he added. The post Merck partners neuroloop on bioelectronic device for inflammation appeared first on.
pharmaphorum
JUNE 10, 2021
It goes without saying that if pharmaceutical companies are not profitable, they will not survive. Nowhere has this need for healthy companies been more apparent than during the current global coronavirus pandemic, with multiple manufacturers making COVID-19 vaccines rapidly available to the public.
Delveinsight
NOVEMBER 29, 2020
Looking at the potential of the pipeline therapies they hold once approved, pharmaceutical companies are charting out a seemingly exciting course in the market. Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market.
The Pharma Data
SEPTEMBER 11, 2020
In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.
pharmaphorum
AUGUST 10, 2020
Research on the social determinants of health indicates that our behaviour accounts for up to 38% of our health status and that we should be looking to broader aspects of health as medical care represents only 11%. In a previous article I argued that behavioural science capabilities are a new skill that pharma needs to master.
Expert insights. Personalized for you.
100 
Let's personalize your content